231 related articles for article (PubMed ID: 30614075)
1. Core fucosylation of copper transporter 1 plays a crucial role in cisplatin-resistance of epithelial ovarian cancer by regulating drug uptake.
Lv X; Song J; Xue K; Li Z; Li M; Zahid D; Cao H; Wang L; Song W; Ma T; Gu J; Li W
Mol Carcinog; 2019 May; 58(5):794-807. PubMed ID: 30614075
[TBL] [Abstract][Full Text] [Related]
2. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
3. MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition.
Cao L; Wan Q; Li F; Tang CE
BMB Rep; 2018 Sep; 51(9):456-461. PubMed ID: 30037365
[TBL] [Abstract][Full Text] [Related]
4. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
5. Core Fucosylation on T Cells, Required for Activation of T-Cell Receptor Signaling and Induction of Colitis in Mice, Is Increased in Patients With Inflammatory Bowel Disease.
Fujii H; Shinzaki S; Iijima H; Wakamatsu K; Iwamoto C; Sobajima T; Kuwahara R; Hiyama S; Hayashi Y; Takamatsu S; Uozumi N; Kamada Y; Tsujii M; Taniguchi N; Takehara T; Miyoshi E
Gastroenterology; 2016 Jun; 150(7):1620-1632. PubMed ID: 26965517
[TBL] [Abstract][Full Text] [Related]
6. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
[TBL] [Abstract][Full Text] [Related]
7. RUNX3 contributes to carboplatin resistance in epithelial ovarian cancer cells.
Barghout SH; Zepeda N; Vincent K; Azad AK; Xu Z; Yang C; Steed H; Postovit LM; Fu Y
Gynecol Oncol; 2015 Sep; 138(3):647-55. PubMed ID: 26186909
[TBL] [Abstract][Full Text] [Related]
8. Loss of core fucosylation suppressed the humoral immune response in Salmonella typhimurium infected mice.
Zahid D; Zhang N; Fang H; Gu J; Li M; Li W
J Microbiol Immunol Infect; 2021 Aug; 54(4):606-615. PubMed ID: 32146162
[TBL] [Abstract][Full Text] [Related]
9. Deletion of core fucosylation on alpha3beta1 integrin down-regulates its functions.
Zhao Y; Itoh S; Wang X; Isaji T; Miyoshi E; Kariya Y; Miyazaki K; Kawasaki N; Taniguchi N; Gu J
J Biol Chem; 2006 Dec; 281(50):38343-50. PubMed ID: 17043354
[TBL] [Abstract][Full Text] [Related]
10. Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity.
Bompiani KM; Tsai CY; Achatz FP; Liebig JK; Howell SB
Metallomics; 2016 Sep; 8(9):951-62. PubMed ID: 27157188
[TBL] [Abstract][Full Text] [Related]
11. Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells.
Beretta GL; Gatti L; Tinelli S; Corna E; Colangelo D; Zunino F; Perego P
Biochem Pharmacol; 2004 Jul; 68(2):283-91. PubMed ID: 15194000
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational modification of E-cadherin by core fucosylation regulates Src activation and induces epithelial-mesenchymal transition-like process in lung cancer cells.
Shao K; Chen ZY; Gautam S; Deng NH; Zhou Y; Wu XZ
Glycobiology; 2016 Feb; 26(2):142-54. PubMed ID: 26443198
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of core fucosylation limits progression of diabetic kidney disease.
Fang M; Kang L; Wang X; Guo X; Wang W; Qin B; Du X; Tang Q; Lin H
Biochem Biophys Res Commun; 2019 Dec; 520(3):612-618. PubMed ID: 31623829
[TBL] [Abstract][Full Text] [Related]
14. Exogenous l-fucose attenuates neuroinflammation induced by lipopolysaccharide.
Xu X; Fukuda T; Takai J; Morii S; Sun Y; Liu J; Ohno S; Isaji T; Yamaguchi Y; Nakano M; Moriguchi T; Gu J
J Biol Chem; 2024 Jan; 300(1):105513. PubMed ID: 38042483
[TBL] [Abstract][Full Text] [Related]
15. Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.
Kalayda GV; Wagner CH; Jaehde U
J Inorg Biochem; 2012 Nov; 116():1-10. PubMed ID: 23010323
[TBL] [Abstract][Full Text] [Related]
16. The SH3 domain in the fucosyltransferase FUT8 controls FUT8 activity and localization and is essential for core fucosylation.
Tomida S; Takata M; Hirata T; Nagae M; Nakano M; Kizuka Y
J Biol Chem; 2020 Jun; 295(23):7992-8004. PubMed ID: 32350116
[TBL] [Abstract][Full Text] [Related]
17. EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer.
Wang X; Jiang P; Wang P; Yang CS; Wang X; Feng Q
PLoS One; 2015; 10(4):e0125402. PubMed ID: 25927922
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
[TBL] [Abstract][Full Text] [Related]
19. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
[TBL] [Abstract][Full Text] [Related]
20. Core fucosylation of μ heavy chains regulates assembly and intracellular signaling of precursor B cell receptors.
Li W; Liu Q; Pang Y; Jin J; Wang H; Cao H; Li Z; Wang X; Ma B; Chi Y; Wang R; Kondo A; Gu J; Taniguchi N
J Biol Chem; 2012 Jan; 287(4):2500-8. PubMed ID: 22084235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
